These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Bortezomib for myeloma -- much ado about something. Dispenzieri A N Engl J Med; 2005 Jun; 352(24):2546-8. PubMed ID: 15958811 [No Abstract] [Full Text] [Related]
5. Successful use of bortezomib in a patient with systemic lupus erythematosus and multiple myeloma. Fröhlich K; Holle JU; Aries PM; Gross WL; Moosig F Ann Rheum Dis; 2011 Jul; 70(7):1344-5. PubMed ID: 21173019 [No Abstract] [Full Text] [Related]
6. The proteasome--an emerging therapeutic target in cancer. Mitchell BS N Engl J Med; 2003 Jun; 348(26):2597-8. PubMed ID: 12826633 [No Abstract] [Full Text] [Related]
19. [Situation of translational research and development of molecular-targeted agents for multiple myeloma]. Kizaki M Nihon Rinsho; 2007 Dec; 65(12):2357-61. PubMed ID: 18069283 [TBL] [Abstract][Full Text] [Related]
20. New treatment approaches in multiple myeloma. Berrebi A Isr Med Assoc J; 2005 Dec; 7(12):820-1. PubMed ID: 16382710 [No Abstract] [Full Text] [Related] [Next] [New Search]